clawmachineonline| The scale of the pharmaceutical and health industry is expected to reach 1.25 trillion yuan in 2026, and the Pharmaceutical ETF(512010) packages core pharmaceutical assets with one click

Category:Animals Date: View:38

On the news front, the Beijing City Government issued the "Beijing City Action Plan to Accelerate Collaborative Innovation in Medicine and Health (2024-2026)", proposing that by 2026, the total scale of the pharmaceutical and health industry will reach 1.clawmachineonline.25 trillion yuan (of which, the operating income of the pharmaceutical industry reached 240 billion yuan), and fixed asset investment exceeded 10 billion yuan per year. Achieve global leadershipclawmachineonlineThere are 5-8 scientific discoveries and technological breakthroughs, and 10 new innovative drugs and 30 innovative medical devices have been approved for marketing; the joint development level of the "three medical services" has been further improved, and 1-2 new research hospitals have been built; introduction and cultivation There are more than 10,000 professional talents at the level; the Municipal Pharmaceutical and Health Industry Investment Fund has leveraged social venture capital of 20 billion yuan every year; and 10 high-quality characteristic parks. The industrial carrying capacity has been further improved and it has global influenceclawmachineonlineThe formation of modern medical and health industry clusters is accelerating.

clawmachineonline| The scale of the pharmaceutical and health industry is expected to reach 1.25 trillion yuan in 2026, and the Pharmaceutical ETF(512010) packages core pharmaceutical assets with one click

CITIC Construction Investment said that the introduction of policies aims to promote the high-quality development of the pharmaceutical and health industry, accelerate the research and development and industrialization of innovative drugs and medical devices, and enhance industrial competitiveness. Innovative drugs are the representative of new quality productivity. The country currently regards biomedicine as a key development industry and actively promotes industrial development, or may enter a new period of rapid development.

Pharmaceutical ETF (512010, OTC Link A/Cclawmachineonline:001344/007883), packaging core pharmaceutical assets in various fields such as innovative drugs, CXO, medical services, and medical devices with one click to help allocate investment opportunities for upward industrial prosperity + low valuation.

The above content and data have nothing to do with the position of Lianyun Channel on the interface and do not constitute investment advice. Operate accordingly and bear the risks at your own risk.

Related articles